Company ProtoKinetix, Incorporated

Equities

PKTX

US7437221002

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 12:14:22 2024-05-17 EDT			5-day change	1st Jan Change
0.0166 ^USD	0.00%		+1.22%	-12.63%

05-15	ProtoKinetix, Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-29	ProtoKinetix, Incorporated announced a financing transaction	CI

ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Companyâs anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. In a clinical setting, AAGP is showing its ability to protect cells from inflammation, repair and replace damaged cells and improve cell survivability over time. The Company has not developed a commercially viable product and has not generated any revenue.

Number of employees: 5

Managers	Title	Age	Since
Clarence Smith CEO	Chief Executive Officer	60	14-05-31
Michael Guzzetta DFI	Director of Finance/CFO	66	17-11-13
Victoria Bantz LAW	General Counsel	-	-

Members of the board	Title	Age	Since
Clarence Smith CEO	Chief Executive Officer	60	14-05-31
Edward McDonough BRD	Director/Board Member	71	15-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	346,713,485	210,825,955 ( 60.81 %)	0	60.81 %

Name	Equities	%	Valuation
Clarence Smith 22.25 %	77,137,093	22.25 %	1 M $
Alexandra Blake Smith 7.990 %	27,700,776	7.990 %	415 512 $
John & Edith Smith 6.766 %	23,458,709	6.766 %	351 881 $
Lachlan Young 2.890 %	10,021,250	2.890 %	150 319 $
Michael Guzzetta 0.2124 %	736,369	0.2124 %	11 046 $
United Bank (Virginia) 0.0146 %	50,600	0.0146 %	759 $
Williams Jones Wealth Management LLC 0.005768 %	20,000	0.005768 %	300 $
Edward McDonough 0.000000 %	0	0.000000 %	- $

Protokinetix, Inc.

109 West Main Street

44618, Dalton

http://www.protokinetix.com

address ProtoKinetix, Incorporated(PKTX)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
PROTOKINETIX, INCORPORATED	-12.63%	5.86M
MODERNA, INC.	+34.27%	50.85B
IQVIA HOLDINGS INC.	+0.62%	42.82B
LONZA GROUP AG	+49.62%	42.03B
CELLTRION, INC.	-4.96%	29.55B
ICON PUBLIC LIMITED COMPANY	+10.82%	26.11B
ALNYLAM PHARMACEUTICALS, INC.	-21.68%	19.13B
BIO-TECHNE CORPORATION	+9.49%	13.05B
MEDPACE HOLDINGS, INC.	+27.09%	12.16B
UNITED THERAPEUTICS CORPORATION	+24.06%	12.08B

Other Biotechnology & Medical Research